With these premises, reproducible animal models of hypoparathyroidism are necessary to dissect the specific effects of PTH deprivation, particularly in the view of treatments such as human recombinant PTH (rhPTH) administration, which has become available but still used only with few indications [8]. The gene discussed is PTH; the disease is hypoparathyroidism.